Trade Solid Biosciences - SLDB CFD

Trading Conditions

• Type: CFD
• Spread: 0.09
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 6.98
• Open: 6.98
• 1-Year Change: -2.1%
• Day's Range: 6.98 - 7.31

What is Solid Biosciences (SLDB)?

Solid Biosciences is a biotechnology company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic disorder characterized by progressive muscle degeneration. The company employs gene therapy and gene editing technologies to address the underlying causes of DMD. Solid Biosciences' research includes the development of gene delivery vectors and molecular treatments aimed at restoring dystrophin protein function. It collaborates with academic and clinical partners to conduct preclinical and clinical studies. The company is committed to advancing treatments that improve muscle function and quality of life for individuals affected by DMD. Solid Biosciences operates research facilities dedicated to genetic medicine and neuromuscular disease. Its work contributes to the broader field of rare genetic disorder therapeutics.

Solid Biosciences Stock Price Today: Live Overview

The price today is shaped by current intraday trading levels as Solid Biosciences trades at $7.19. The share price has oscillated between $6.92 and $7.34, registering a daily change of +2.149%.

FAQ: Solid Biosciences (SLDB)

What is the current price of SLDB stock?

Solid Biosciences is currently trading at $7.19.

Does SLDB pay dividends?

Solid Biosciences does not pay dividends.

Does SLDB have a formal corporate presence or regional headquarters in the UAE?

Solid Biosciences has no regional office or subsidiary in the UAE and relies on partners for market access.

What is SLDB best known for?

Solid Biosciences is most famous for developing gene therapies for Duchenne muscular dystrophy.

What assets are typically shown together with SLDB?

Commonly shown alongside SLDB: Valneva SE, Ypsomed, Millicom International Cellular SA